New MRI techniques aim to spot heart disease without radiation
NCT ID NCT01399385
First seen Jun 24, 2026 · Last updated Aug 05, 2026 · Updated 5 times
Summary
This study is testing new magnetic resonance imaging (MRI) techniques to get clearer pictures of the heart and blood vessels without using radiation. Researchers will compare these new MRI methods to standard tests like angiography and CT scans. Up to 4,000 adults—including healthy volunteers and people with or at risk for heart disease—will take part. No treatment is given; the goal is to improve how doctors diagnose heart disease.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could lead to safer, radiation-free MRI methods for diagnosing heart disease and understanding blood vessel health.
- What could go wrong
- This is a technical development study, not a treatment trial. The new MRI methods may not prove better than existing tests, and results are exploratory.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATHEROSCLEROSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
National Institutes of Health Clinical Center
RECRUITINGBethesda, Maryland, 20892, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new stomach and gut bypass surgery tackle obesity and diabetes?
- Could a new oral drug change future treatments? early safety trial begins
- Can brain scans unlock the secret to hearing in crowded rooms?
- Can a Light-Guided device make arterial sticks easier?
- Water workouts could be the key to back pain relief
- Could a new oral drug pass its first safety hurdle?